<DOC>
	<DOCNO>NCT01504646</DOCNO>
	<brief_summary>The primary aim study evaluate effect Lyprinol® supplementation airway inflammation bronchoconstrictor response dry air hyperpnea individual asthma . The investigator hypothesize Lyprinol® supplementation , compare placebo , significantly attenuate airway inflammation hyperpnea-induced bronchoconstriction asthmatic individual .</brief_summary>
	<brief_title>Effect Component Fish Oil Exercise-Induced Bronchoconstriction Airway Inflammation Asthma</brief_title>
	<detailed_description>Our research group show , numerous occasion fish oil markedly protective effect suppress airway inflammation exercise-induced bronchoconstriction elite athlete asthmatic individual . Purified fish oil marine lipid fraction PCSO-524™ ( Lyprinol™ ) use supplementation study asthma [ 2 , 10 , 11 ] . While fish oil rich source omega-3 fatty acid eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) , Lyprinol® patent extract stabilized lipid New Zealand green-lipped mussel , Perna canaliculus , combine olive oil vitamin E. EPA DHA main ingredient fish oil , thus similarity Lyprinol fish oil term mechanism action . Thus , aim show Lyprinol® modulate inflammatory eicosanoids exert anti-inflammatory effect .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Lyprinol</mesh_term>
	<criteria>Have diagnose asthma EIB . Evidence diagnosis asthma include medication use well history symptom outline NHLBI Guidelines Diagnosis Management Asthma . For diagnosis EIB , subject must demonstrate fall FEV1 ≥ 10 % dry air eucapnic voluntary hyperventilation ( EVH ) , simulate exercise challenge ; FEV1 measure lung function Not currently take fish oil supplement Limit fish consumption 1 fish meal per week course study Severe asthma indicate . These subject identify postEVH drop FEV1 great 50 % first lab test session history severe asthmarelated event hospitalization emergency room visit . Only mild moderate asthmatic ( i.e . subject whose FEV1 drop 1050 % ) include study . They take currently take asthma maintenance medication They pregnant They history hyperlipidemia ( high cholesterol ) , hypertension , diabetes , bleed disorder , delay clotting time , seizure disorder They allergic shellfish , fish , corn , soy product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Exercise-Induced Bronchoconstriction</keyword>
	<keyword>lipid</keyword>
	<keyword>n-3 PUFA</keyword>
	<keyword>airway inflammation</keyword>
	<keyword>Bronchoconstriction</keyword>
</DOC>